Page 2 - Multiple Sclerosis Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple sclerosis program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple Sclerosis Program Today - Breaking & Trending Today

Tolebrutinib associated with long-term safety, efficacy in relapsing-remitting MS

BOSTON — Treatment with tolebrutinib 60 mg per day was safe and associated with low annualized relapse rate and stable disability through 120 weeks, according to research presented at the American Academy of Neurology annual meeting.“In the MS field, we need treatments that can better target both peripheral and centrally mediated inflammation, and I think there is a lot of hope for ....

United States , Eli Lilly , Byrobert Herpen , Heather Biele , University Of Toronto , Sclerosis Program At St , American Academy Of Neurology , Robert Herpen , American Academy , Multiple Sclerosis Program , Expanded Disability Status Scale ,